Diagnostic, Therapeutic and Reproductive Aspects of Patients With Mullerian Anomalies (MULAN)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
AgeUp to 45
SponsorUniversity Hospital, Ghent
About this trial
The purpose of this study is to get a better understanding of the clinical implications (including reproductive problems and obstetric complications), appropriate diagnostic tools and correct surgical treatment of Mullerian anomalies.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
women with a uterus
presence of a mullerian variation
Maximum age 45y
Disqualifiers
women without a uterus
aged >45y
Trial population
diagnosed and/or treated in the Ghent University Hospital
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
1,000 Participants
are grouped into 1 trial groupGroup A: patients with a mullerian variation
Trial outcomes
Primary outcomes
1
Fertility
Time to clinical pregnancy
Time frame
10 years after trying to conceive2
Fertility
Early pregnancy loss
Time frame
18 weeks after conception3
Surgical approach
Different surgical approaches used
Time frame
during surgery4
Surgical success
Relief of symptoms after surgery
Time frame
15 years after surgerySecondary outcomes
1
Diagnostic accuracy
The ability of a test to detect a Mullerian variation when it is present and detect the absence of a Mullerian variation when it is absent
Time frame
at the time of diagnostic workup2
Obstetric complications
Complications during pregnancy, labor, delivery, and the postpartum period
Time frame
1 year after conceptionSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov